Sarepta Therapeutics, Inc. SRPT Business Segments — Manufacturing Costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ManufacturingCosts.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — manufacturing costs?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — manufacturing costs of $19.76M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — manufacturing costs changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — manufacturing costs decreased by 70.7% year-over-year, from $67.47M to $19.76M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — manufacturing costs?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — manufacturing costs has grown at a -23.5% compound annual growth rate (CAGR), from $466.11M to $208.83M.
- What does business segments — manufacturing costs mean?
- Includes all direct and indirect costs associated with the manufacturing and production processes of the segment's products. This metric is essential for evaluating the scalability and cost-effectiveness of the segment's supply chain operations.